Laxmi Dental Q1FY27 Revenue Hits Record ₹747 Crore

Financial Performance Highlights

Q1FY27 Consolidated Financials (INR millions):

Revenue: ₹747.0 crore (13.9% YoY growth from ₹656.0 crore in Q1FY26)
Gross Profit: ₹587.0 crore (22.1% YoY growth)
Gross Profit Margin: 78.6% (vs 73.3% in Q1FY26 and 70.5% in Q4FY26)
EBITDA: ₹143.6 crore (20.6% YoY growth)
EBITDA Margin: 19.2% (vs 18.2% in Q1FY26)
EBIT: ₹123.4 crore (22.7% YoY growth)
EBIT Margin: 16.5% (vs 15.3% in Q1FY26)
Profit Before Tax: ₹120.4 crore (25.5% YoY growth)
PAT before share of profit from JVs: ₹95.5 crore (30.7% YoY growth)
PAT after share of profit from JVs: ₹103.2 crore (23.8% YoY growth)
PAT Margin: 13.8% (vs 12.7% in Q1FY26)
Basic EPS: ₹1.87 (vs ₹1.53 in Q1FY26)
Diluted EPS: ₹1.87 (vs ₹1.52 in Q1FY26)
Adjusted EBITDA: ₹159.6 crore (8.0% YoY growth)

Business Segment Performance:

Dental Laboratory Business: Grew 23.5% YoY
International Operations: Grew 37.4% YoY
Aligner Solutions Business: Grew 28.6% YoY
Bizdent growth: 27.8% YoY
Vedia growth: 29.3% YoY

Expense Analysis:

Employee Cost: ₹284.2 crore (increased sequentially due to appointment of new CEO for USA business and sales team additions)
Other Expenses: ₹159.2 crore (increased due to higher freight cost, ECL provisions, and AI automation initiatives)
ESOP Expenses: ₹8.3 crore (non-cash, vs ₹18.4 crore in Q1FY26)
Finance Cost: ₹3.0 crore (vs ₹4.6 crore in Q1FY26)
Depreciation & Amortization: ₹43.2 crore
Other Income: ₹23.0 crore

Operational and Strategic Updates

Geographic Expansion:

Strengthened on-ground leadership presence in US market
Established 3 new support facilities across multiple Indian cities to deepen regional presence

Digital Initiatives:

Continued progress in digitalization and innovation
AI-led automation initiatives for operational efficiency improvements
Deployed more than 160 intraoral scanners in India
Launched iScanPro branded intraoral scanners

Market Position:

Second largest player in domestic laboratory business
Largest export laboratory in India
Only integrated dental products company in India
Comprehensive portfolio including crowns, abutments, dentures, clear aligners, aligner sheets, thermo-forming machines, intraoral scanners, and paediatric crowns

Brand Development:

Focus on establishing well-recognized brand through celebrity endorsements, IPL advertisements, and participation in IDS Event Germany
Increasing share of revenues from branded offerings

Management Commentary

Rajesh Khakhar (Chairperson and Whole-Time Director) stated: "We are pleased to report a strong start to FY27, with Q1 revenue reaching our highest-ever quarterly level of around ₹75.0 crore, representing year-on-year growth of 13.9%. The performance was broad-based, led by healthy momentum in our Dental Laboratory business and our Aligner Solutions business. Our profitability during the quarter witnessed some improvement largely on account of a better product mix."

Sameer Merchant (Managing Director and CEO) added: "Our robust performance in Q1FY27 reflects the sustained efforts of our sales and operations teams, supported by scanner deployments in the past, training programs, promotional activities, participation in dental events and digital initiatives."

Forward-looking Statements

Management indicated focus on core dental portfolio, deeper market penetration, AI-led automation, and improving operational efficiencies to deliver healthy and sustainable performance. The presentation contains forward-looking statements subject to risks including fluctuations in earnings, growth management, competition, economic conditions, and regulatory changes.

Additional Information

Presentation available on company website: https://www.laxmidentallimited.com/for-investors
Investor Relations contact: Strategic Growth Advisors Pvt Ltd.
ESOP expenses are non-cash in nature
Revenue excludes Kids-e-Dental and IDBG AI Dent as per Ind AS norms for jointly controlled entities
Adjusted EBITDA calculation: Reported EBITDA + ESOP expenses + 60% of Kids-e-dental PAT + 49% of IDBG AI Dent PAT